Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Apraglutide

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ironwood Pharma To Present HCP Views On Tpn Impact In (SBS)
    Ironwood Pharma To Present HCP Views On Tpn Impact In (SBS)

    23 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-23/ironwood-pharmaceuticals-to-share-real-world-hcp-perspectives-on-burden-of-total-parenteral-nutritio

    PHARMIWEB
    23 Apr 2026
    Share Share
    Ironwood Pharmaceuticals Reports Fourth Quarter 2025 Result
    Ironwood Pharmaceuticals Reports Fourth Quarter 2025 Result

    25 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-25/ironwood-pharmaceuticals-reports-fourth-quarter-and-full-year-2025-results-achieves-2025-financial

    PHARMIWEB
    25 Feb 2026
    Share Share
    Ironwood Pharmaceuticals Updates on Apraglutide Clinical Trials
    Ironwood Pharmaceuticals Updates on Apraglutide Clinical Trials

    14 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250414687154/en/Ironwood-Pharmaceuticals-Provides-Clinical-and-Regulatory-Update-on-Apraglutide

    BUSINESSWIRE
    14 Apr 2025
    Share Share
    Ironwood Submits Apraglutide NDA, Updates Corporate Structure
    Ironwood Submits Apraglutide NDA, Updates Corporate Structure

    29 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250129150325/en

    BUSINESSWIRE
    29 Jan 2025
    Share Share
    Ironwood makes bid for $1B GI drug with subgroup data
    Ironwood makes bid for $1B GI drug with subgroup data

    29 Oct 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/ramping-fda-submission-ironwood-makes-further-bid-1b-gi-drug-subgroup-data

    FIERCE BIOTECH
    29 Oct 2024
    Share Share
    Ironwood Presents Apraglutide SBS-IF Data At DDW Late-Breaker
    Ironwood Presents Apraglutide SBS-IF Data At DDW Late-Breaker

    21 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240521515089/en

    BUSINESSWIRE
    21 May 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.